Paper

Abstract 100: Blood-based integration of epigenomic profiles, TMB, and MSI to predict immune checkpoint inhibitor response in advanced non-small cell lung cancer (aNSCLC).

Cancer Research · 2026 · Sean Gordon, Jing Wang, Shile Zhang et al.